Need more? Try out  Advanced Search (20+ criteria)»


Last Update

This profile was last updated on 9/28/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Alfredo Galvez?

Alfredo F. Galvez

Chief Scientist

Soy Labs LLC

HQ Phone:  (573) 582-7399

Direct Phone: (573) ***-****direct phone

Email: a***@***.com


+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.


  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Soy Labs LLC

651 Commerce Road

Mexico, Missouri,65265

United States

Company Description

Soy Labs is the premier soy-based ingredient supplier to the nutrition industry. The company spearheads research and develops proprietary soy peptides, ingredients, and formulaic compounds for inclusion in nutritional supplements, cosmeceuticals, soyfoods, fun...more

Background Information

Employment History

Chief Scientific Officer

Missouri Plant Science Center

Director of Research

Missouri Plant Science Center

Adjunct Assistant Professor

University of Missouri

Postdoctoral Researcher

University of California

Center Scientist (Collaborator)

University of California , Davis


SL Technology

Chief Scientific Officer

Missouri Plant Science Center

Lead Scientific Advisor


Lead Scientific Advisor

Mexico Public Schools

Lead Scientific Advisor


Lead Scientific Advisor



Genetics and Plant Physiology

University of the Philippines at Los Banos

M.S. degrees

Genetics and Plant Physiology

University of the Philippines at Los Banos


University of California at Davis Center of Excellence for Nutritional Genomics & University of Missouri at Columbia


Washington State University



University of California , Davis


Genetics and Molecular Biology

UC Davis



University of California Davis

Web References(72 Total References)

Dr. Alfredo Galvez
Project Scientist, Center for Nutritional Genetics, UC Davis and Chief Scientific Advisor for Soy Labs Tech Inc., USA

Alfredo F. Galvez, Ph.D.
Project Scientist, Center of Excellence for Nutritional Genomics, University of California, Davis, CA Chief Scientific Officer, SL Technology, Inc., Chesterfield, MO Alfredo F. Galvez, Ph.D. is currently the Chief Scientific Officer of SL Tech, Inc., a Reliv subsidiary company, working on the development of functional foods and nutraceutical ingredients based on the lunasin peptide, a soy protein component he serendipitously discovered in 1996 as a postdoctoral researcher at UC Berkeley. He has a PhD in Genetics from UC Davis, majoring in molecular biology and cytogenetics. He is also a Project Scientist at the Center for Nutritional Genomics, University of California at Davis, working on elucidating the molecular mechanism of lunasin as a peptidomimetic of a human tumor suppressor. Dr. Galvez earned his B.S. and M.S. degrees in Genetics and Plant Physiology from the University of the Philippines at Los Banos, and his Ph.D. in Genetics from the University of California, Davis. After completing his Ph.D., Dr. Galvez worked for the USDA-ARS at Washington State University and at the University of California Berkeley as a Research Biochemist and Geneticist.

The discoverer of lunasin, Dr Galvez, has spent the past decade cross-breeding varieties of soy to create a non-GMO variant that is high in lunasin content, and in developing methods for extracting the lunasin for commercial sale.
All Reliv nutritional supplements are soy-based, but Dr Galvez, the chief scientist at SoyLabs and the discoverer of Lunasin, has done studies to show that purified lunasin taken in a gelcap (as with LunaRichX) can provide the epigenetic benefits without triggering a reaction to soy. Dr. Alfredo Galvez, the scientist who first discovered lunasin, notes that exhibits significant anti-inflammatory properties. "In developing LunaRich for Reliv, we have maximized lunasin levels in soy." he addition of LunaRich comes less than a month after the CDC published findings from the National Health and Nutrition Examination Survey indicating metabolic syndrome continues to rise among Americans. [cached]

According to Dr. Alfredo Galvez, lead scientific advisor with Missouri-based Soy Labs, LLC, some of the "megatrends" that are driving the nutrition market in general are directly impacting this category."An aging population, lack of confidence in traditional health care systems and globalization/consumer access to information are compelling shoppers to be proactive and seek alternative solutions to their health concerns," he said.
"Most cholesterol is produced in the liver by the HMG-CoA reductase gene.Statin drugs work by blocking HMGCoA, but they can often block too much," Galvez explained. "This leads to serious side effects because our body needs a minimum level of cholesterol for proper cellular functions such as maintaining cell membrane integrity and hormone production. According to Galvez, lunasin works differently: it targets cholesterol at an earlier stage than statins, reducing the HMG-CoA without blocking it entirely. "Lunasin demonstrates superior support for cardiovascular health and exhibits significant anti-inflammatory properties," he added. Compared to statins, lunasin works at an earlier stage in the process than prescription statins by reducing the expression of the HMG-CoA Reductase gene, according to Galvez. "While cholesterol is an accepted biomarker for identifying the risk factors associated with cardiovascular disease, other potential biomarkers (e.g. inflammation markers, circulating free fatty acids, etc.) are being identified that may play and equally important role in heart health," Galvez agreed. "The key to future innovations in this segment will be finding bioactive compounds that work synergistically to support heart health by addressing the many inter-related health indicators." Further, a new take on statins may be forthcoming. "Recently research is considering the use of low-dose statin treatment for primary prevention of cardiovascular disease," Galvez added.

Alumni UP LB and current lead advisor for Soy Labs LLC in Missouri U.S.A., Dr. Alfredo Galvez recently gave a media talk about the Soy peptide called Lunasin, which is said to be key to having good heart health and other advantages.
"In the 1990s, there were already several studies about how daily soy consumption reduced the risk of heart disease. Lunasin, which by the way, goes back to my Filipino roots, because the word Lunas means 'solution'," he says. When from the right plants and properly processed, Lunasin can help head off heart disease by working in the liver to carry out cholesterol synthesis and produce less cholesterol, and increasing LDL receptors to help extract more cholesterol from the blood stream, and thereby prevent plaque buildup in the arteries. "Sometimes, even a healthy diet and exercise may not be enough to prevent cholesterol problems," he cautions.

Similar Profiles


Browse ZoomInfo's Business
Contact Directory by City


Browse ZoomInfo's
Business People Directory


Browse ZoomInfo's
Advanced Company Directory